Dimosthenis Pandis, MD, Partho P. Sengupta, MD, Javier Castillo, MD, Guiseppe Caracciolo, MD, PhD, Gregory W. Fischer, MD, Jagat Narula, MD, PhD, Anelechi C. Anyanwu, MD, and David H. Adams, MD
The optimal timing of mitral valve repair (MVr) in patients with chronic severe degenerative mitral regurgitation (MR) remains controversial and is broadly based on either measurable loss of systolic function, as determined by left ventricular (LV) ejection fraction (LVEF) and/or LV cha...